131 related articles for article (PubMed ID: 27289002)
1. A computational analysis of the genetic and transcript diversity at the kallikrein locus.
Lai J; An J; Srinivasan S; Clements JA; Batra J
Biol Chem; 2016 Dec; 397(12):1307-1313. PubMed ID: 27289002
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
Avgeris M; Scorilas A
Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?
Tan OL; Whitbread AK; Clements JA; Dong Y
Biol Chem; 2006 Jun; 387(6):697-705. PubMed ID: 16800730
[TBL] [Abstract][Full Text] [Related]
4. Mining for single nucleotide variants (SNVs) at the kallikrein locus with predicted functional consequences.
Sukumar N; Scott E; Dimitromanolakis A; Misiak A; Prassas I; Diamandis EP; Konvalinka A
Biol Chem; 2014 Sep; 395(9):1037-50. PubMed ID: 25153386
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function.
Dong Y; Matigian N; Harvey TJ; Samaratunga H; Hooper JD; Clements JA
Biol Chem; 2008 Feb; 389(2):99-109. PubMed ID: 18163887
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology.
Adamopoulos PG; Kontos CK; Scorilas A
Genomics; 2019 Jul; 111(4):642-652. PubMed ID: 29614347
[TBL] [Abstract][Full Text] [Related]
7. Identification and molecular cloning of novel transcripts of the human kallikrein-related peptidase 10 (KLK10) gene using next-generation sequencing.
Adamopoulos PG; Kontos CK; Scorilas A
Biochem Biophys Res Commun; 2017 Jun; 487(4):776-781. PubMed ID: 28419837
[TBL] [Abstract][Full Text] [Related]
8. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
Teo CR; Casey PJ; Rasheed SA
Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
[TBL] [Abstract][Full Text] [Related]
9. Integrated genomic characterization of the kallikrein gene locus in cancer.
Girgis AH; Bui A; White NM; Yousef GM
Anticancer Res; 2012 Mar; 32(3):957-63. PubMed ID: 22399617
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4.
Harvey TJ; Hooper JD; Myers SA; Stephenson SA; Ashworth LK; Clements JA
J Biol Chem; 2000 Dec; 275(48):37397-406. PubMed ID: 10969073
[TBL] [Abstract][Full Text] [Related]
11. The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions.
Clements J; Hooper J; Dong Y; Harvey T
Biol Chem; 2001 Jan; 382(1):5-14. PubMed ID: 11258672
[TBL] [Abstract][Full Text] [Related]
12. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.
Lawrence MG; Lai J; Clements JA
Endocr Rev; 2010 Aug; 31(4):407-46. PubMed ID: 20103546
[TBL] [Abstract][Full Text] [Related]
13. The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer.
White NM; Youssef YM; Fendler A; Stephan C; Jung K; Yousef GM
Biol Chem; 2012 Apr; 393(5):379-89. PubMed ID: 22505520
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases.
Batra J; O'Mara T; Patnala R; Lose F; Clements JA
Biol Chem; 2012 Dec; 393(12):1365-90. PubMed ID: 23667899
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary history of tissue kallikreins.
Pavlopoulou A; Pampalakis G; Michalopoulos I; Sotiropoulou G
PLoS One; 2010 Nov; 5(11):e13781. PubMed ID: 21072173
[TBL] [Abstract][Full Text] [Related]
16. Old genes and new genes: the evolution of the kallikrein locus.
Lundwall A
Thromb Haemost; 2013 Sep; 110(3):469-75. PubMed ID: 23571662
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
Pasic MD; Olkhov E; Bapat B; Yousef GM
Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
[TBL] [Abstract][Full Text] [Related]
18. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
[TBL] [Abstract][Full Text] [Related]
19. Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.
Bayani J; Marrano P; Graham C; Zheng Y; Li L; Katsaros D; Lassus H; Butzow R; Squire JA; Diamandis EP
Mol Oncol; 2011 Feb; 5(1):48-60. PubMed ID: 20800559
[TBL] [Abstract][Full Text] [Related]
20. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer].
Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
